Among the 329 patients included in the analysis, the mean age was 53±13 years, and 74% were women. The average duration of ...

A Surrey health trust says it is to become the first in the UK to trial a drug for a debilitating eye condition.Frimley ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...

The thyroid gland, located at the neck's base, controls metabolism, growth, and development. Its hormones impact nearly every ...

South Korea: A recent study published in Ophthalmology Science has found that a deep learning (DL)-driven method for measuring proptosis in thyroid eye disease (TED) patients using standard facial ...

This collaboration will focus on the design and development of a non-viral vector for the delivery of cSIRT6 to the eye, with the aim of addressing ocular diseases more effectively. Dr. Eric Leire ...

Dr Cockerham said that this survey confirms that “the quality of life of patients with chronic thyroid eye disease was reported to be significantly impaired and nearly identical to scores seen in ...

Furthermore, this study reported that the duration of consumption of these herbs was inversely associated with these diseases ... There are many types of thyroid tumors, and some can be quite ...

Reproxalap, a reactive aldehyde species modulator, is approved for dry eye disease, reducing ocular redness. A phase 3 trial with 132 patients confirmed reproxalap's efficacy over a control in ...

Older age and high clinical activity score lowered the odds for response to glucocorticoids in thyroid eye disease. More research is needed comparing glucocorticoids with teprotumumab and other ...